Brief: Trevena Reports Favorable TRV045 Topline Safety And Tolerability Data From Proof-Of-Concept Studies

Trevena

16/10/2023 12:15

Oct 16 (Reuters) - Trevena Inc  TRVN.O :
    * TREVENA REPORTS FAVORABLE TRV045 TOPLINE SAFETY AND
TOLERABILITY
DATA FROM PROOF-OF-CONCEPT STUDIES
    * TREVENA INC: TRV045 WAS WELL TOLERATED WITH RESULTS
GENERALLY
CONSISTENT WITH PRIOR FIRST-IN-HUMAN STUDY
    * TREVENA INC: NO DRUG-RELATED ADVERSE EVENTS AND NO SERIOUS
ADVERSE EVENTS REPORTED
    * TREVENA INC: NO DRUG-RELATED LYMPHOPENIA, BRADYCARDIA, OR
CHANGE
IN BLOOD PRESSURE REPORTED

Source text for Eikon:  ID:nGNX5bxsTs 
Further company coverage:  TRVN.O 

 ((Reuters.Briefs@thomsonreuters.com))